The Only Complete Online Marketing Firm
Thursday, September 15, 2016
EASD: Novel SGLT2 Drug Works in Triple Therapy (CME/CE)
(MedPage Today) -- Ertugliflozin improved T2D control atop metformin/sitagliptin
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment